HINT1 protein cooperates with cannabinoid 1 receptor to negatively regulate glutamate NMDA receptor activity

Molecular Brain

Volumn 6, Issue 1, 2013, Pages

  Vicente Sánchez, Ana ^a   Sánchez Blázquez, Pilar ^a   Rodríguez Muñoz, María ^a   Garzón, Javier ^a  

^a INSTITUTO CAJAL   (Spain)

Author keywords

Cannabinoid receptor; Cortical neuron cultures; Excitotoxicity; HINT1 protein; Neuroprotection; NMDA receptor

Indexed keywords

CANNABINOID 1 RECEPTOR; G PROTEIN COUPLED RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PROTEIN HINT1; SEROTONIN 1A RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; AUTOPHOSPHORYLATION; BRAIN CELL; CELL PROTECTION; CONTROLLED STUDY; EXCITOTOXICITY; LENTIVIRINAE; MOUSE; NEUROPROTECTION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SYNAPTOSOME; ZINC METABOLISM;

ANIMALS; BENZOXAZINES; CELL SURVIVAL; CELLS, CULTURED; CEREBRAL CORTEX; LENTIVIRUS; MICE; MORPHOLINES; N-METHYLASPARTATE; NAPHTHALENES; NERVE TISSUE PROTEINS; NEURONS; NEUROPROTECTIVE AGENTS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE I; PROTEIN BINDING; PROTEIN SUBUNITS; RECEPTOR, CANNABINOID, CB1; RECEPTORS, N-METHYL-D-ASPARTATE; RECEPTORS, OPIOID, MU; ZINC;

EID: 84884945604     PISSN: None     EISSN: 17566606     Source Type: Journal    
DOI: 10.1186/1756-6606-6-42     Document Type: Article

References (91)

1. G-protein-coupled receptors act via protein kinase C and Src to regulate NMDA receptors. Lu WY, Xiong ZG, Lei S, Orser BA, Dudek E, Browning MD, et al. Nat Neurosci 1999 2 331 338 10.1038/7243 10204539
2. Src kinases: a hub for NMDA receptor regulation. Salter MW, Kalia LV, Nat Rev Neurosci 2004 5 317 328 15034556
3. The Mu-Opioid receptor and the NMDA receptor associate in PAG neurons: implications in pain control. Rodríguez-Muñoz M, Sánchez-Blázquez P, Vicente-Sánchez A, Berrocoso E, Garzón J, Neuropsychopharmacology 2012 37 338 349 10.1038/npp.2011.155 21814188
4. Sustained potentiation of NMDA receptor-mediated glutamate responses through activation of protein kinase C by a m opioid. Chen L, Huang LY, Neuron 1991 7 319 326 10.1016/0896-6273(91)90270-A 1678615
5. Cannabinoid receptors couple to NMDA receptors to reduce the production of NO and the mobilization of zinc induced by glutamate. Sánchez- Blázquez P, Rodríguez-Muñoz M, Vicente-Sánchez A, Garzón J, Antioxid Redox Signal 2013 10.1089/ars.2012.5100
6. The histidine triad nucleotide-binding protein 1 supports mu-opioid receptor-glutamate NMDA receptor cross-regulation. Rodríguez-Muñoz M, Sánchez-Blázquez P, Vicente-Sánchez A, Bailón C, Martín-Aznar B, Garzón J, Cell Mol Life Sci 2011 68 2933 2949 10.1007/s00018-010-0598-x 21153910
7. Role of mPKCI, a novel mu-opioid receptor interactive protein, in receptor desensitization, phosphorylation, and morphine-induced analgesia. Guang W, Wang H, Su T, Weinstein IB, Wang JB, Mol Pharmacol 2004 66 1285 1292 10.1124/mol.66.5. 15496510
8. Glutamate receptor phosphorylation and trafficking in pain plasticity in spinal cord dorsal horn. Liu XJ, Salter MW, Eur J Neurosci 2010 32 278 289 10.1111/j.1460-9568.2010.07351.x 20629726
9. Signaling pathways from cannabinoid receptor-1 activation to inhibition of N-methyl-D-aspartic acid mediated calcium influx and neurotoxicity in dorsal root ganglion neurons. Liu Q, Bhat M, Bowen WD, Cheng J, J Pharmacol Exp Ther 2009 331 1062 1070 10.1124/jpet.109.156216 19752241
10. Cannabinoids produce neuroprotection by reducing intracellular calcium release from ryanodine-sensitive stores. Zhuang SY, Bridges D, Grigorenko E, McCloud S, Boon A, Hampson RE, et al. Neuropharmacology 2005 48 1086 1096 10.1016/j.neuropharm.2005.01.005 15910885
11. Modulation of NMDA and AMPA-mediated synaptic transmission by CB1 receptors in frontal cortical pyramidal cells. Li Q, Yan H, Wilson WA, Swartzwelder HS, Brain Res 2010 1342 127 137 20420813
12. Pre- and postsynaptic distribution of cannabinoid and mu opioid receptors in rat spinal cord. Hohmann AG, Briley EM, Herkenham M, Brain Res 1999 822 17 25 10.1016/S0006-8993(98)01321-3 10082879
13. A light and electron microscopic study of the CB1 cannabinoid receptor in the primate spinal cord. Ong WY, Mackie K, J Neurocytol 1999 28 39 45 10.1023/A:1007011700677 10573606
14. Pre- and postsynaptic localizations of the CB1 cannabinoid receptor in the dorsal horn of the rat spinal cord. Salio C, Fischer J, Franzoni MF, Conrath M, Neuroscience 2002 110 755 764 10.1016/S0306-4522(01)00584-X 11934482
15. Involvement of cannabinoid receptors in the regulation of neurotransmitter release in the rodent striatum: a combined immunochemical and pharmacological analysis. Kofalvi A, Rodrigues RJ, Ledent C, Mackie K, Vizi ES, Cunha RA, et al. J Neurosci 2005 25 2874 2884 10.1523/JNEUROSCI.4232-04.2005 15772347
16. Ultrastructural localization of the CB1 cannabinoid receptor in mu-opioid receptor patches of the rat Caudate putamen nucleus. Rodriguez JJ, Mackie K, Pickel VM, J Neurosci 2001 21 823 833 11157068
17. Cannabinoid receptor stimulation is anti-inflammatory and improves memory in old rats. Marchalant Y, Cerbai F, Brothers HM, Wenk GL, Neurobiol Aging 2008 29 1894 1901 10.1016/j.neurobiolaging.2007.04.028 17561311
18. Gz mediates the long-lasting desensitization of brain CB1 receptors and is essential for cross-tolerance with morphine. Garzón J, de la Torre-Madrid E, Rodríguez-Muñoz M, Vicente-Sánchez A, Sánchez-Blázquez P, Mol Pain 2009 5 11 10.1186/1744-8069-5-11 19284549
19. Reduced expression of glutamate receptors and phosphorylation of CREB are responsible for in vivo Delta9-THC exposure-impaired hippocampal synaptic plasticity. Fan N, Yang H, Zhang J, Chen C, J Neurochem 2010 112 691 702 10.1111/j.1471-4159.2009.06489.x 19912468
20. Hint, Fhit, and GalT: function, structure, evolution, and mechanism of three branches of the histidine triad superfamily of nucleotide hydrolases and transferases. Brenner C, Biochemistry 2002 41 9003 9014 10.1021/bi025942q 12119013
21. Three-dimensional structure of human protein kinase C interacting protein 1, a member of the HIT family of proteins. Lima CD, Klein MG, Weinstein IB, Hendrickson WA, Proc Natl Acad Sci U S A 1996 93 5357 5362 10.1073/pnas.93.11. 5357 8643579
22. Properties and distribution of the protein inhibitor (Mr 17,000) of protein kinase C. McDonald JR, Groschel-Stewart U, Walsh MP, Biochem J 1987 242 695 705 3593270
23. Hits, Fhits and Nits: beyond enzymatic function. Huebner K, Saldivar JC, Sun J, Shibata H, Druck T, Adv Enzyme Regul 2011 51 208 217 10.1016/j.advenzreg. 2010.09.003 21035495
24. The histidine triad protein Hint1 triggers apoptosis independent of its enzymatic activity. Weiske J, Huber O, J Biol Chem 2006 281 27356 27366 10.1074/jbc.M513452200 16835243
25. Hint1 is a haplo-insufficient tumor suppressor in mice. Li H, Zhang Y, Su T, Santella RM, Weinstein IB, Oncogene 2006 25 713 721 10.1038/sj.onc.1209111 16186798
26. Beta-catenin takes a HIT. Huber O, Weiske J, Cell Cycle 2008 7 1326 1331 10.4161/cc.7.10.5926 18596417
27. Histidine triad nucleotide-binding protein 1 (HINT1) regulates Ca(2+) signaling in mouse fibroblasts and neuronal cells via store-operated Ca(2+) entry pathway. Linde CI, Feng B, Wang JB, Golovina VA, Am J Physiol Cell Physiol 2013 304 1098 C1104 10.1152/ajpcell.00073.2013 23576580
28. RGSZ1 interacts with protein kinase C interacting protein PKCI-1 and modulates mu opioid receptor signaling. Ajit SK, Ramineni S, Edris W, Hunt RA, Hum WT, Hepler JR, et al. Cell Signal 2007 19 723 730 10.1016/j.cellsig.2006.09. 008 17126529
29. NMDAR-nNOS generated zinc recruits PKCgamma to the HINT1-RGS17 complex bound to the C terminus of mu-opioid receptors. Rodríguez-Muñoz M, Torre-Madrid E, Sánchez-Blázquez P, Wang JB, Garzón J, Cell Signal 2008 20 1855 1864 10.1016/j.cellsig.2008.06.015 18652891
30. NO-released zinc supports the simultaneous binding of Raf-1 and PKCgamma cysteine-rich domains to HINT1 protein at the mu-opioid receptor. Rodríguez-Muñoz M, Torre-Madrid E, Sánchez-Blázquez P, Garzón J, Antioxid Redox Signal 2011 14 2413 2425 10.1089/ars.2010. 3511 21235400
31. GPCRs promote the release of zinc ions mediated by nNOS/NO and the Redox transducer RGSZ2 protein. Sánchez-Blázquez P, Rodríguez- Muñoz M, Bailón C, Garzón J, Antioxid Redox Signal 2012 17 1163 1177 10.1089/ars.2012.4517 22563771
32. Direct association of mu-opioid and NMDA glutamate receptors supports their cross-regulation: molecular implications for opioid tolerance. Garzón J, Rodríguez-Muñoz M, Sánchez-Blazquez P, Curr Drug Abuse Rev 2012 5 199 226 10.2174/1874473711205030199 22920535
33. Nitric oxide and zinc-mediated protein assemblies involved in mu opioid receptor signaling. Rodríguez-Muñoz M, Garzón J, Mol Neurobiol 2013 10.1007/s12035-013-8465-z
34. Locus-specific rescue of GluRe1 NMDA receptors in mutant mice identifies the brain regions important for morphine tolerance and dependence. Inoue M, Mishina M, Ueda H, J Neurosci 2003 23 6529 6536 12878694
35. Inhibition of morphine tolerance and dependence by the NMDA receptor antagonist MK-801. Trujillo KA, Akil H, Science 1991 251 85 87 10.1126/science.1824728 1824728
36. Paradigm shift in neuroprotection by NMDA receptor blockade: memantine and beyond. Lipton SA, Nat Rev Drug Discov 2006 5 160 170 10.1038/nrd1958 16424917
37. Khiari G, d'Amato T, Dalery J, Gaha L: Glutaminergic hypothesis of schizophrenia: clinical research studies with ketamine. Mechri A, Saoud M, Encéphale 2001 27 53 59 24011459
38. Zarate Jr CA: The role of glutamate in mood disorders: results from the ketamine in major depression study and the presumed cellular mechanism underlying its antidepressant effects. Maeng S, Curr Psychiatry Rep 2007 9 467 474 10.1007/s11920-007-0063-1 18221626
39. Ketamine produces effective and long-term pain relief in patients with Complex Regional Pain Syndrome Type 1. Sigtermans MJ, van Hilten JJ, Bauer MC, Arbous MS, Marinus J, Sarton EY, et al. Pain 2009 145 304 311 10.1016/j.pain.2009.06.023 19604642
40. Electrophysiologic analysis of preemptive effects of spinal opioids on N-methyl-D-aspartate receptor-mediated events. Chapman V, Haley JE, Dickenson AH, Anesthesiology 1994 81 1429 1435 10.1097/00000542-199412000-00018 7992912
41. Involvement of brain-derived neurotrophic factor in cannabinoid receptor-dependent protection against excitotoxicity. Khaspekov LG, Brenz Verca MS, Frumkina LE, Hermann H, Marsicano G, Lutz B, Eur J Neurosci 2004 19 1691 1698 10.1111/j.1460-9568.2004.03285.x 15078543
42. Molecular mechanisms of cannabinoid protection from neuronal excitotoxicity. Kim SH, Won SJ, Mao XO, Jin K, Greenberg DA, Mol Pharmacol 2006 69 691 696 16299067
43. Cannabinoid receptor localization in brain. Herkenham M, Lynn AB, Little MD, Johnson MR, Melvin LS, de Costa BR, et al. Proc Natl Acad Sci U S A 1990 87 1932 1936 10.1073/pnas.87.5.1932 2308954
44. Cannabinoids inhibit N- and P/Q-type calcium channels in cultured rat hippocampal neurons. Twitchell W, Brown S, Mackie K, J Neurophysiol 1997 78 43 50 9242259
45. Rethinking the excitotoxic ionic milieu: the emerging role of Zn(2+) in ischemic neuronal injury. Sensi SL, Jeng JM, Curr Mol Med 2004 4 87 111 10.2174/1566524043479211 15032707
46. Glutamate released from glial cells synchronizes neuronal activity in the hippocampus. Angulo MC, Kozlov AS, Charpak S, Audinat E, J Neurosci 2004 24 6920 6927 10.1523/JNEUROSCI.0473-04.2004 15295027
47. Neuronal synchrony mediated by astrocytic glutamate through activation of extrasynaptic NMDA receptors. Fellin T, Pascual O, Gobbo S, Pozzan T, Haydon PG, Carmignoto G, Neuron 2004 43 729 743 10.1016/j.neuron.2004.08.011 15339653
48. Properties of synaptically evoked astrocyte calcium signal reveal synaptic information processing by astrocytes. Perea G, Araque A, J Neurosci 2005 25 2192 2203 10.1523/JNEUROSCI.3965-04.2005 15745945
49. Adenylyl cyclase activation modulates activity-dependent changes in synaptic strength and Ca2+/calmodulin-dependent kinase II autophosphorylation. Makhinson M, Chotiner JK, Watson JB, O'Dell TJ, J Neurosci 1999 19 2500 2510 10087064
50. Retinoic acid regulates the developmental expression of dopamine D2 receptor in rat striatal primary cultures. Valdenaire O, Maus-Moatti M, Vincent JD, Mallet J, Vernier P, J Neurochem 1998 71 929 936 9721718
51. Developmental regulation of 5-HT2 and 5-HT1c mRNA and receptor levels. Roth BL, Hamblin MW, Ciaranello RD, Brain Res Dev Brain Res 1991 58 51 58 10.1016/0165-3806(91)90236-C 2015654
52. Down-regulation of 3H-lofentanil binding to opiate receptors in different cultured neuronal cells. Maloteaux JM, Octave JN, Laterre EC, Laduron PM, Naunyn Schmiedebergs Arch Pharmacol 1989 339 192 199 2566925
53. The plasticity of the association between mu-opioid receptor and glutamate ionotropic receptor N in opioid analgesic tolerance and neuropathic pain. Sánchez-Blázquez P, Rodríguez-Muñoz M, Berrocoso E, Garzón J, Eur J Pharmacol 2013 10.1016/j.ejphar.2013.01.066
54. PDZ domain proteins of synapses. Kim E, Sheng M, Nat Rev Neurosci 2004 5 771 781 15378037
55. mPins modulates PSD-95 and SAP102 trafficking and influences NMDA receptor surface expression. Sans N, Wang PY, Du Q, Petralia RS, Wang YX, Nakka S, et al. Nat Cell Biol 2005 7 1179 1190 10.1038/ncb1325 16299499
56. Regulation of dopamine D1 receptor function by physical interaction with the NMDA receptors. Pei L, Lee FJ, Moszczynska A, Vukusic B, Liu F, J Neurosci 2004 24 1149 1158 10.1523/JNEUROSCI.3922-03.2004 14762133
57. Direct interaction enables cross-talk between ionotropic and group I metabotropic glutamate receptors. Perroy J, Raynaud F, Homburger V, Rousset MC, Telley L, Bockaert J, et al. J Biol Chem 2008 283 6799 6805 10.1074/jbc. M705661200 18182392
58. Synaptic versus extrasynaptic NMDA receptor signalling: implications for neurodegenerative disorders. Hardingham GE, Bading H, Nat Rev Neurosci 2010 11 682 696 10.1038/nrn2911 20842175
59. Cell pathology in mood disorders. Rajkowska G, Semin Clin Neuropsychiatry 2002 7 281 292 10.1053/scnp.2002.35228 12382210
60. Peripheral profiling analysis for bipolar disorder reveals markers associated with reduced cell survival. Herberth M, Koethe D, Levin Y, Schwarz E, Krzyszton ND, Schoeffmann S, et al. Proteomics 2011 11 94 105 10.1002/pmic.201000291 21182197
61. Acute behavioral effects of nicotine in male and female HINT1 knockout mice. Jackson KJ, Wang JB, Barbier E, Chen X, Damaj MI, Genes Brain Behav 2012 10.1111/j.1601-183X.2012.00827.x
62. CB1 cannabinoid receptors and on-demand defense against excitotoxicity. Marsicano G, Goodenough S, Monory K, Hermann H, Eder M, Cannich A, et al. Science 2003 302 84 88 10.1126/science.1088208 14526074
63. Stimulated D(1) dopamine receptors couple to multiple Galpha proteins in different brain regions. Jin LQ, Wang HY, Friedman E, J Neurochem 2001 78 981 990 10.1046/j.1471-4159.2001.00470.x 11553672
64. Enhanced activation of Akt and extracellular-regulated kinase pathways by simultaneous occupancy of Gq-coupled 5-HT2A receptors and Gs-coupled 5-HT7A receptors in PC12 cells. Johnson-Farley NN, Kertesy SB, Dubyak GR, Cowen DS, J Neurochem 2005 92 72 82 10.1111/j.1471-4159.2004.02832.x 15606897
65. Agonists determine the pattern of G-protein activation in mu-opioid receptor-mediated supraspinal analgesia. Sánchez-Blázquez P, Gómez-Serranillos P, Garzón J, Brain Res Bull 2001 54 229 235 10.1016/S0361-9230(00)00448-2 11275413
66. Evidence for the coupling of Gq protein to D1-like dopamine sites in rat striatum: possible role in dopamine-mediated inositol phosphate formation. Wang HY, Undie AS, Friedman E, Mol Pharmacol 1995 48 988 994 8848015
67. Glycosylated phosducin-like protein long regulates opioid receptor function in mouse brain. Garzón J, Rodríguez-Díaz M, López-Fando A, García-España A, Sánchez- Blázquez P, Neuropharmacology 2002 42 813 828 10.1016/S0028-3908(02) 00027-8 12015208
68. Tyrosine phosphorylation of the NR2B subunit of the NMDA receptor in the spinal cord during the development and maintenance of inflammatory hyperalgesia. Guo W, Zou S, Guan Y, Ikeda T, Tal M, Dubner R, et al. J Neurosci 2002 22 6208 6217 12122079
69. Zinc selectively blocks the action of N-methyl-D-aspartate on cortical neurons. Peters S, Koh J, Choi DW, Science 1987 236 589 593 10.1126/science. 2883728 2883728
70. Separating dual effects of zinc at recombinant N-methyl-D-aspartate receptors. Williams K, Neurosci Lett 1996 215 9 12 10.1016/S0304-3940(96)12924-4 8880741
71. Regulation of NMDA channel function by endogenous Ca(2+)-dependent phosphatase. Lieberman DN, Mody I, Nature 1994 369 235 239 10.1038/369235a0 7514273
72. Ca2+-calmodulin and protein kinase Cs: a hypothetical synthesis of their conflicting convergences on shared substrate domains. Chakravarthy B, Morley P, Whitfield J, Trends Neurosci 1999 22 12 16 10.1016/S0166-2236(98)01288-0 10088994
73. Differential tyrosine phosphorylation of N-methyl-D-aspartate receptor subunits. Lau LF, Huganir RL, J Biol Chem 1995 270 20036 20041 10.1074/jbc.270.34.20036 7544350
74. Tyrosine kinase potentiates NMDA receptor currents by reducing tonic zinc inhibition. Zheng F, Gingrich MB, Traynelis SF, Conn PJ, Nat Neurosci 1998 1 185 191 10.1038/634 10195142
75. Inhibition of protein phosphatase 2B upregulates serine phosphorylation of N-methyl-D-aspartate receptor NR1 subunits in striatal neurons in vivo. Choe ES, Shin EH, Wang JQ, Neurosci Lett 2005 384 38 43 10.1016/j.neulet.2005.04.044 15890444
76. Therapeutic implications for striatal-enriched protein tyrosine phosphatase (STEP) in neuropsychiatric disorders. Goebel-Goody SM, Baum M, Paspalas CD, Fernandez SM, Carty NC, Kurup P, et al. Pharmacol Rev 2012 64 65 87 10.1124/pr.110.003053 22090472
77. Calmodulin mediates calcium-dependent inactivation of N-methyl-D-aspartate receptors. Zhang S, Ehlers MD, Bernhardt JP, Su CT, Huganir RL, Neuron 1998 21 443 453 10.1016/S0896-6273(00)80553-X 9728925
78. Interactions of calmodulin and alpha-actinin with the NR1 subunit modulate Ca2+-dependent inactivation of NMDA receptors. Krupp JJ, Vissel B, Thomas CG, Heinemann SF, Westbrook GL, J Neurosci 1999 19 1165 1178 9952395
79. Displacement of alpha-actinin from the NMDA receptor NR1 C0 domain by Ca2+/calmodulin promotes CaMKII binding. Merrill MA, Malik Z, Akyol Z, Bartos JA, Leonard AS, Hudmon A, et al. Biochemistry 2007 46 8485 8497 10.1021/bi0623025 17602661
80. Phosphorylation-dependent regulation of N-methyl-D-aspartate receptors by calmodulin. Hisatsune C, Umemori H, Inoue T, Michikawa T, Kohda K, Mikoshiba K, et al. J Biol Chem 1997 272 20805 20810 10.1074/jbc.272.33.20805 9252405
81. Characterization of protein kinase A and protein kinase C phosphorylation of the N-methyl-D-aspartate receptor NR1 subunit using phosphorylation site-specific antibodies. Tingley WG, Ehlers MD, Kameyama K, Doherty C, Ptak JB, Riley CT, et al. J Biol Chem 1997 272 5157 5166 10.1074/jbc.272.8.5157 9030583
82. Heatstroke-induced cerebral ischemia and neuronal damage. Involvement of cytokines and monoamines. Lin MT, Ann N Y Acad Sci 1997 813 572 580 10.1111/j.1749-6632.1997.tb51748.x 9100936
83. Prevention and repair of circulatory shock and cerebral ischemia/injury by various agents in experimental heatstroke. Chang CK, Chang CP, Chiu WT, Lin MT, Curr Med Chem 2006 13 3145 3154 10.2174/092986706778742945 17168703
84. Mu-opioid receptor blockade protects against circulatory shock and cerebral ischemia during heatstroke. Chen ZC, Kuo JR, Huang YP, Lin MT, J Cardiovasc Pharmacol 2005 46 754 760 10.1097/01.fjc.0000187173.67661.a9 16306798
85. Ipsapirone and ketanserin protects against circulatory shock, intracranial hypertension, and cerebral ischemia during heatstroke. Chang CP, Chen SH, Lin MT, Shock 2005 24 336 340 10.1097/01.shk.0000175894.18168.66 16205318
86. Regulation of N-methyl-D-aspartic acid (NMDA) receptors by metabotropic glutamate receptor 7. Gu Z, Liu W, Wei J, Yan Z, J Biol Chem 2012 287 10265 10275 10.1074/jbc.M111.325175 22287544
87. Neuroprotection against hypoxia/ischemia: delta-opioid receptor-mediated cellular/molecular events. He X, Sandhu HK, Yang Y, Hua F, Belser N, Kim DH, et al. Cell Mol Life Sci 2012
88. The glutamate receptor ion channels. Dingledine R, Borges K, Bowie D, Traynelis SF, Pharmacol Rev 1999 51 7 61 10049997
89. Behavioral despair in mice: a primary screening test for antidepressants. Porsolt RD, Bertin A, Jalfre M, Arch Int Pharmacodyn Ther 1977 229 327 336 596982
90. A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Bennett GJ, Xie YK, Pain 1988 33 87 107 10.1016/0304-3959(88)90209-6 2837713
91. Endocannabinoids mediate neuron-astrocyte communication. Navarrete M, Araque A, Neuron 2008 57 883 893 10.1016/j.neuron.2008.01.029 18367089